3 results
Approved WMOCompleted
Part 1:The primary objective of the study is to investigate whether treatment with natalizumab slows the accumulation of disability not related to relapses in subjects with SPMS. The secondary objectives of this study are to determine in this study…
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with relapsing PMR compared to placebo.
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with newly diagnosed PMR compared to placebo.